-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Dedifferentiated_Melanoma_RNAseq
Study
EGAS00001003601
-
Oral mucosa organoids as a potential model for personalized therapies
Study
EGAS00001003628
-
Single cell RNA sequencing of lung adenocarcinoma.
Study
EGAS00001003681
-
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
Study
EGAS00001003746
-
Small_molecule_inhibitors_in_melanoma___Kenski___Kong___WES
Study
EGAS00001002863
-
Genomics_of_acral_lentiginous_melanoma
Study
EGAS00001003740
-
Whole Genome Sequencing of HCC
Study
EGAS00001002888
-
2014_Lung_sq_WES
Study
EGAS00001002844
-
WGS/RNA-seq pair of an inflammatory hepatocellular adenoma (IHCA)
Study
EGAS00001003025
-
Whole Exome Sequencing in Multiple Myeloma
Study
EGAS00001003227
-
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Study
EGAS00001003212
-
Adeno-associated virus in the liver: natural history and consequences in tumor development
Study
EGAS00001003310
-
Uveal melanoma patient with germline MBD4 nonsense mutation
Study
EGAS00001003362
-
Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers
Study
EGAS00001003452
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal_LCM
Study
EGAS00001003455
-
Chordoma_Extension_Study
Study
EGAS00001000892
-
Chordoma_Extension__known_cancer_genes_
Study
EGAS00001000895
-
Myeloma_Follow_up_Pilot
Study
EGAS00001000743
-
ICGC medulloblastoma whole genome sequencing data, ICGC release 16
Study
EGAS00001000744
-
ICGC Oesophageal adenocarcinoma - 100 tumour samples
Study
EGAS00001000724
-
Diverse modes of genomic alterations in hepatocellular carcinoma
Study
EGAS00001000824
-
RNAseq___Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000813
-
Identification_of_drug_resistance_genes_in_melanoma_by_mRNA_gene_expression
Study
EGAS00001000815
-
Identification_of_drug_resistance_genes_in_melanoma_by_small_RNAs_expression_analysis
Study
EGAS00001000816
-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830
-
Primary_angiosarcoma_Whole_Genome_Sequencing
Study
EGAS00001000851
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
Skin Adenocarcinoma Genome Sequencing
Study
EGAS00001001052
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Barcelona_kids_with_melanoma
Study
EGAS00001000733
-
CRISPR_screen_M14__NCI_H3122
Study
EGAS00001001060
-
Genetic_profiling_of_mucosal_melanoma
Study
EGAS00001001115
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
Anaplastic_Meningioma_V3__cancer_gene_panel
Study
EGAS00001001155
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
Study
EGAS00001001214
-
Anaplastic_Meningioma_WGS_X10
Study
EGAS00001000859
-
Mechanisms_of_patient_response_to_Dabrafenib_in_Melanoma
Study
EGAS00001000946
-
Cross-species genomics identifies TAF12, NFYC and RAD54L as novel choroid plexus carcinoma oncogenes
Study
EGAS00001000961
-
71 Whole-exome sequencing of Esophageal Squamous Cell Carcinoma on Chinese Patients
Study
EGAS00001001475
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
BAP1_sequence_of_uveal_melanoma_cell_lines
Study
EGAS00001001520
-
Genetic landscape of relapsed DLBCL
Study
EGAS00001001553
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Melanoma_C32_ENU_resistance_to_Combination_Therapy
Study
EGAS00001001614
-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
Melanoma_C32_ENU_Resistance_to_Single_Agent_Therapy
Study
EGAS00001001697
-
Onco-exaptation of an Endogenous Retroviral LTR Drives IRF5 Expression in Hodgkin Lymphoma
Study
EGAS00001001205